These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 8673997)
41. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Koga H; Sakisaka S; Ohishi M; Kawaguchi T; Taniguchi E; Sasatomi K; Harada M; Kusaba T; Tanaka M; Kimura R; Nakashima Y; Nakashima O; Kojiro M; Kurohiji T; Sata M Hepatology; 1999 Mar; 29(3):688-96. PubMed ID: 10051469 [TBL] [Abstract][Full Text] [Related]
42. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185 [TBL] [Abstract][Full Text] [Related]
43. [Thyroxine-binding globulin--not a tumor marker of hepatocellular cancer]. Sieg A; Schönpflug A; Seitz HK; Kommerell B Z Gastroenterol; 1991 Mar; 29(3):101-4. PubMed ID: 1647573 [TBL] [Abstract][Full Text] [Related]
44. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas. Tsujimura A; Kawamura N; Ichimura T; Honda K; Ishiko O; Ogita S Int J Oncol; 2002 Feb; 20(2):361-5. PubMed ID: 11788902 [TBL] [Abstract][Full Text] [Related]
45. Correlation of HBV and HCV with CH, LC, HCC in liver biopsied tissue at Rajavithi Hospital. Komindr A; Praditphol N; Suphanpayak S; Sae-Eaw R; Nussati A; Tujinda S; Kongteeraphap P; Intaraksa S; Rukchampong R; Deesawat T J Med Assoc Thai; 2005 Jun; 88(6):788-809. PubMed ID: 16083220 [TBL] [Abstract][Full Text] [Related]
46. DNA fragmentation and cell proliferation correlated with tumor grade in patients with hepatocellular carcinoma. Kalogeraki A; Garbagnati F; Santinami M; Zoras O Cancer; 2002 Oct; 96(5):301-5. PubMed ID: 12378598 [TBL] [Abstract][Full Text] [Related]
47. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727 [TBL] [Abstract][Full Text] [Related]
48. [Telomere length and telomerase activity in hepatocellular carcinoma]. Nakashio R; Kitamoto M; Nakanishi T; Takaishi H; Takahashi S; Kajiyama G Nihon Rinsho; 1998 May; 56(5):1239-43. PubMed ID: 9613130 [TBL] [Abstract][Full Text] [Related]
49. Diagnosis of hepatocellular carcinoma (HCC) in a high-risk patient by using transgastric EUS-guided fine-needle biopsy (EUS-FNA). Hollerbach S; Reiser M; Topalidis T; König M; Schmiegel W Z Gastroenterol; 2003 Oct; 41(10):995-8. PubMed ID: 14562197 [TBL] [Abstract][Full Text] [Related]
51. Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma. Mizuno H; Honda M; Shirasaki T; Yamashita T; Yamashita T; Mizukoshi E; Kaneko S Liver Int; 2012 Aug; 32(7):1146-55. PubMed ID: 22372738 [TBL] [Abstract][Full Text] [Related]
52. Annexin A2 as a differential diagnostic marker of hepatocellular tumors. Longerich T; Haller MT; Mogler C; Aulmann S; Lohmann V; Schirmacher P; Brand K Pathol Res Pract; 2011 Jan; 207(1):8-14. PubMed ID: 20971570 [TBL] [Abstract][Full Text] [Related]
53. Telomerase activity of needle-biopsied liver samples: its usefulness for diagnosis and judgement of efficacy of treatment of small hepatocellular carcinoma. Komine F; Shimojima M; Moriyama M; Amaki S; Uchida T; Arakawa Y J Hepatol; 2000 Feb; 32(2):235-41. PubMed ID: 10707863 [TBL] [Abstract][Full Text] [Related]
54. Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study. Zhang L; Liu H; Sun L; Li N; Ding H; Zheng J Acta Histochem; 2012 Oct; 114(6):547-52. PubMed ID: 22119409 [TBL] [Abstract][Full Text] [Related]
55. [Clinical significance of telomerase activity in precancerous lesion of the liver (adenomatous hyperplasia)]. Nishimoto A; Miura N; Oshimura M Nihon Rinsho; 1998 May; 56(5):1244-7. PubMed ID: 9613131 [TBL] [Abstract][Full Text] [Related]
56. [Expression features of glypican-3 and its diagnostic and differential values in hepatocellular carcinoma]. Bian YZ; Yao DF; Zhang CG; Li SS; Wu W; Dong ZZ; Qiu LW; Yu DD Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):260-5. PubMed ID: 21586223 [TBL] [Abstract][Full Text] [Related]
57. Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm. Wang F; Jing X; Wang T; Li G; Li T; Zhang Q; Huang Y; Li J; Wang Y; Gao Y; Han T; Du Z Am J Clin Pathol; 2012 Jun; 137(6):937-45. PubMed ID: 22586053 [TBL] [Abstract][Full Text] [Related]
58. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. Di Tommaso L; Destro A; Seok JY; Balladore E; Terracciano L; Sangiovanni A; Iavarone M; Colombo M; Jang JJ; Yu E; Jin SY; Morenghi E; Park YN; Roncalli M J Hepatol; 2009 Apr; 50(4):746-54. PubMed ID: 19231003 [TBL] [Abstract][Full Text] [Related]
59. Glypican-3 immunostaining significantly improves histological diagnosis of hepatocellular carcinoma. Honsová E; Lodererová A; Franková S; Oliverius M; Trunecka P Cas Lek Cesk; 2011; 150(1):37-40. PubMed ID: 21400962 [TBL] [Abstract][Full Text] [Related]
60. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Pawlik TM; Gleisner AL; Anders RA; Assumpcao L; Maley W; Choti MA Ann Surg; 2007 Mar; 245(3):435-42. PubMed ID: 17435551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]